The latest developmental drugs, particularly for the use in oncology, rely on the targeted degradation of harmful...

A major side effect of pre-operative radiation therapy in patients with non-metastatic STS is an increased risk of ...

Repotrectinib has been designed to help patients with NSCLC that have a genetic rearrangement in their tumour cells ...

A new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of...

Presenting results from the phase Ib STAR clinical trial to the 34th EORTC-NCI-AACR Symposium on Molecular Targets and ...

Researchers have identified a range of genetic alterations in glioma brain cancers that will help them to understand...

A new Northwestern Medicine study identifies common and rare gene mutations that impact radiation resistance and...

Results from a single-arm phase 2 study of 32 patients with various cancer types harboring the rare AKT1 E17K mutation...

Pancreatic cancer's stealth-like nature has the attention of University of Florida scientists, who have discovered...

About one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders...

Cardiorespiratory fitness, measured by peak oxygen uptake (VO2peak), is regarded as one of the most significant...

Cancer cells can swiftly adapt to stop targeted medicines from working by attaching directly to and hindering the ...